Radiation dosimetry results from a phase II trial of Ibritumomab Tiuxetan (Zevalin™) radioimmunotherapy for patients with non-Hodgkin's lymphoma and mild thrombocytopenia

Gregory A. Wiseman, Thomas E. Witzig, Christine A. White, Bryan R. Leigh, William D. Erwin, Richard B. Sparks, Donald A. Podoloff, Russell J. Schilder, Nancy L. Bartlett, Stewart M. Spies, Antonio J. Grillo-López

Research output: Contribution to journalArticlepeer-review

27 Scopus citations

Fingerprint Dive into the research topics of 'Radiation dosimetry results from a phase II trial of Ibritumomab Tiuxetan (Zevalin™) radioimmunotherapy for patients with non-Hodgkin's lymphoma and mild thrombocytopenia'. Together they form a unique fingerprint.

Medicine & Life Sciences